Altaf A Wani, PhD

Altaf Wani


College of Medicine



Academic Title

Faculty Emeritus

Research Program

Molecular Carcinogenesis and Chemoprevention

Research Interest

DNA Damage ● Xeroderma Pigmentosum ● Cell Transformation, Neoplastic ● Ovarian Cancer ● Cancer ● Breast Cancer ● Li-Fraumeni Syndrome

Altaf Wani, PhD, is a member of the Molecular Carcinogenesis and Chemoprevention Program at the OSUCCC – James, where his research focuses on molecular carcinogenesis analysis, fine mapping and cellular processing of DNA damage responses.

One of his recent studies revealed an unappreciated regulatory mode involving the interaction between DNA damage-binding protein 2 (DDB2) and developmentally downregulated 4-Like (NEDD4L) in ovarian cancer cells. The novel mechanism suggests DDB2-mediated fine-tuning of transforming growth factor beta signaling and its downstream effects that mitigate ovarian cancer growth.

Dr. Wani is the co-author of many articles in well-known publications, including Cell Cycle, Nucleic Acids Research, Molecular Cancer Research and Journal of Biological Chemistry.

Office Location

736 Biomedical Research Tower

460 W 12th Ave, Columbus, OH 43210



Back to Researcher Search

Please enter a keyword (i.e. Name, Research Interest) or choose a Research Program


Please enter a keyword (i.e. Name, Cancer Type) or choose a Principle Investigator


Search for Clinical Trials

Find a Scientific Publication